Evidence map›Paper›PMID 40770348›Full record

ArticleJournal of translational medicine2025

Fibro-NPC: a pathogenic subtype identified at single-cell resolution with secreted SFRP4 as a biomarker in intervertebral disc degeneration.

Yili Xu, Zuozhi Xie, Shubo Gu, Xiang Zhao, Di Zhao, Zhengzheng Wu, Jinfeng Wang, Tao Xu, Ruxue Xu, Zhenhua Feng and 5 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Genetic interaction betweenbioRxiv : the preprint server for biology · 2026
    Article
  3. Genetic interaction betweenResearch square · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yili Xu *Division of Spine Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210008, China.
Zuozhi Xie *Division of Spine Surgery, Department of Orthopedic Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, China.
Shubo Gu *Division of Spine Surgery, Department of Orthopedic Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, China.
Xiang ZhaoDepartment of Surgery of Spine and Spinal Cord, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Henan, 453003, Zhengzhou, China.
Di ZhaoDepartment of Ultrasound, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing, 21008, China. wtongyu0618@163.com.
Zhengzheng WuDivision of Spine Surgery, Department of Orthopedic Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, China.
Jinfeng WangDivision of Spine Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210008, China.
Tao XuDivision of Spine Surgery, Department of Orthopedic Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, China.
Ruxue XuSchool of Clinical Medicine, Bengbu Medical University, Bengbu, 233000, Anhui, China.
Zhenhua FengDivision of Spine Surgery, Department of Orthopedic Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, China.
Yong QiuDivision of Spine Surgery, Department of Orthopedic Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, China.
Zezhang ZhuDivision of Spine Surgery, Department of Orthopedic Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, China.
Yang YuDivision of Spine Surgery, Department of Orthopedic Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, China.
Bo ShiDivision of Spine Surgery, Department of Orthopedic Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, China. jmsshitou@163.com.
Jun JiangDivision of Spine Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Clinical College of Nanjing University of Chinese Medicine, Nanjing, 210008, China. spine821107@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntervertebral disc degeneration (IDD) is a primary cause of low back pain and, in severe cases, can lead to disability. Current treatments for low back pain remain limited in efficacy, underscoring the need for a deeper understanding of the molecular mechanisms driving IDD. The degeneration process is primarily driven by an imbalance in the extracellular matrix, largely due to the senescence of nucleus pulposus cells (NPCs).

methodsThrough single-cell sequencing of degenerated nucleus pulposus tissue from five intervertebral discs, we identified five distinct NPC subtypes. Notably, fibrosis-associated NPCs (Fibro-NPC) were predominantly observed at the terminal stage of cell differentiation, identifying Fibro-NPC as a pathogenic subtype in IDD. To further explore intercellular interactions, we used the CellChat algorithm to construct a cell communication network encompassing the diverse cell types in the nucleus pulposus. Mass spectrometry analysis of normal and degenerated tissue subsequently identified seven core proteins associated with IDD. Among these, WGCNA and machine learning highlighted SFRP4 as a central pathogenic protein, highly expressed in Fibro-NPC.

resultsAdvanced differentiation of nucleus pulposus cells, particularly the Fibro-NPC subtype, is associated with the secretion of SFRP4, which accelerates cellular senescence. This senescence contributes to fibrosis within the nucleus pulposus, along with angiogenesis and inflammatory infiltration in the nucleus pulposus microenvironment. Collectively, these processes drive intervertebral disc degeneration.

conclusionsOur findings position SFRP4 as a biomarker for IDD, presenting a novel target for its diagnosis and treatment.

Indexed as

BiomarkersIntervertebral Disc DegenerationNucleus PulposusSingle-Cell AnalysisAdultCell DifferentiationCellular SenescenceFemaleFibrosisHumansMaleMiddle AgedProto-Oncogene ProteinsSecreted Frizzled-Related ProteinsBiomarkersProto-Oncogene ProteinsSecreted Frizzled-Related ProteinsSFRP4 protein, humanIntervertebral disc degenerationLabel-free quantitative proteomicsNucleus pulposusSenescenceSingle-cell sequencing

Identifiers

PMID40770348
PMCPMC12326596

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.